Psilocybin combined with psychotherapy shows early promise for anorexia nervosa, with pilot data indicating symptom relief, safety, and high treatment acceptability

Psilocybin-assisted psychotherapy shows early potential as a treatment for anorexia nervosa, a condition with high mortality and few effective interventions. Pilot findings indicate the approach was feasible, generally well tolerated, and associated with reductions in eating disorder symptoms for some participants. Treatment combined psilocybin dosing with talk therapy rather than relying on the drug alone. That pairing matters because anorexia often involves rigid thinking, distorted self-perception, and entrenched behavioral patterns that may respond to both altered states and structured psychological support. The results remain preliminary because pilot studies are small and not designed to prove efficacy. Still, the combination of safety, acceptability, and symptom improvement supports larger controlled trials to test whether psilocybin can become a meaningful option in eating disorder care.